Furthermore, poly (I:C) can mediate tumor cell apoptosis and activate NK cells 42,43 Currently, TLR3 ligands are being tested either alone or in combination with chemotherapeutics or immunotherapeutics in several cancer immunotherapy trials. The gene discussed is TLR3; the disease is cancer.